212
Views
0
CrossRef citations to date
0
Altmetric
Review

Small patients, big challenges: navigating pediatric drug manipulations to prevent medication errors - a comprehensive review

, , ORCID Icon &
Pages 1489-1509 | Received 25 Jul 2023, Accepted 18 Oct 2023, Published online: 24 Oct 2023

References

  • Bowles A, Keane J, Ernest T, et al. Specific aspects of gastro-intestinal transit in children for drug delivery design. Int J Pharmaceut. 2010;395(1–2):37–43. doi: 10.1016/j.ijpharm.2010.04.048
  • Hawcutt DB, Cooney L, Oni L, et al. Precision dosing in children. Expert Rev Precis Med Drug Dev. 2016;1(1):69–78. doi: 10.1080/23808993.2016.1138845
  • Dunne J, Rodriguez WJ, Murphy MD, et al. Extrapolation of adult data and other data in pediatric drug-development programs. Pediatrics. 2011;128:e1242–9. doi: 10.1542/peds.2010-3487
  • European Medicines Agency. Reflection paper: formulation of choice for the paediatric population (EMEA/CHMP/PEG/194810/2005). European Medicines Agency 2006; EMEA/CHMP/:p. 1–45. [Accessed 30 May, 2023]
  • Barker CIS, Standing JF, Kelly LE, et al. Pharmacokinetic studies in children: recommendations for practice and research. Archives Of Disease In Childhood 2018. 2018;archdischild-2017–314506.
  • Committee on Human Medicinal Products (CHMP). Guideline on pharmaceutical development of medicines for paediatric use. European Medicines Agency 2013. [Accessed 3 Jun, 2023]
  • Field MJ, Boat TF. Safe and effective medicines for children: pediatric studies conducted under the best Pharmaceuticals for children Act and the pediatric research equity Act. 2012. doi: 10.17226/13311
  • Boosting the development of medicines for children. [Accessed 2023 Aug 30]. Document available at: https://www.ema.europa.eu/en/documents/report/boosting-development-medicines-children-closing-report-european-medicines-agency-european-commission_en.pdf
  • Commission E. State of Paediatric Medicines in the EU. 10 years of the EU paediatric Regulation. Report from the Commission to the European Parliament and the Council 2017.
  • Strickley RG, Iwata Q, Wu S, et al. Pediatric drugs-A review of commercially available oral formulations. J Pharmaceut sci. 2008;97(5):1731–1774. doi: 10.1002/jps.21101
  • Kölch M, Schnoor K, Fegert JM. The EU-regulation on medicinal products for paediatric use: impacts on child and adolescent psychiatry and clinical research with minors. Eur Child Adolesc Psychiatry. 2007;16:229–235. doi: 10.1007/s00787-006-0594-8
  • Thomsen MDT. Global pediatric drug development. Curr Ther Res Clin Exp. 2019;90:135–142. doi: 10.1016/j.curtheres.2019.02.001
  • Rei Bolislis W, Bejeuhr G, Benzaghou F, et al. Optimizing pediatric medicine developments in the European union through pragmatic approaches. Clin Pharmacol Ther. 2021;110:871–879. doi: 10.1002/cpt.2152
  • WHO Expert Committee on Specifications for Pharmaceutical Preparations. Annex 5 development of paediatric medicines: points to consider in formulation. Expert Committee on Specifications for Pharm Prep. 2012;197–225.
  • World Health Organization. Shaping the global innovation and access landscape for better paediatric medicines: global accelerator for paediatric formulations 2022-2024 business plan. 2022.
  • Chaudri NA. Adherence to long-term therapies evidence for action. Ann Saudi Med. 2004;24(3):221–222. doi: 10.5144/0256-4947.2004.221
  • Tomlin S, Cockrill H, Costello I, et al. Making medicines safer for children— guidance for the use of unlicensed medicines in paediatric patients. J Nerv Ment Dis. 2009 [Accessed 30 May, 2023];211(1):1–4. doi: 10.1097/NMD.0000000000001606
  • Carmack M, Berde C, Monuteaux MC, et al. Off-label use of prescription analgesics among hospitalized children in the United States. Pharmacoepidemiol Drug Saf. 2020;29(4):474–481. doi: 10.1002/pds.4978
  • Lajoinie A, Henin E, Nguyen KA, et al. Oral drug dosage forms administered to hospitalized children: analysis of 117,665 oral administrations in a French paediatric hospital over a 1-year period. Int J Pharmaceut. 2016;500(1–2):336–344. doi: 10.1016/j.ijpharm.2016.01.048
  • Karavasili C, Gkaragkounis A, Fatouros DG. Patent landscape of pediatric-friendly oral dosage forms and administration devices. Expert Opin Ther Patents. 2021;31:663–686. doi: 10.1080/13543776.2021.1893691
  • Walsh J, Bickmann D, Breitkreutz J, et al. Delivery devices for the administration of paediatric formulations: overview of current practice, challenges and recent developments. Int J Pharmaceut. 2011;415(1–2):221–231. doi: 10.1016/j.ijpharm.2011.05.048
  • Strickley RG. Pediatric oral formulations: an updated review of commercially available pediatric oral formulations since 2007. J Pharmaceut sci. 2019;108:1335–1365. doi: 10.1016/j.xphs.2018.11.013
  • Allen HC, Garbe MC, Lees J, et al. Off-label medication use in children, more common than we think: a systematic review of the literature. J Oklahoma State Med Assoc. 2018;111:776–783. PMID: 31379392; PMCID: PMC6677268.
  • Lee J-H, Byon H-J, Choi S, et al. Safety and efficacy of off-label and unlicensed medicines in children. J Korean Med Sci. 2018;33:e227. doi: 10.3346/jkms.2018.33.e227
  • Beatriz GC, María José O, Inés JL, et al. Medication errors in children visiting pediatric emergency departments. Farmacia Hospitalaria. 2023;47(4):141–147. doi: 10.1016/j.farma.2023.03.006
  • Panagioti M, Khan K, Keers RN, et al. Prevalence, severity, and nature of preventable patient harm across medical care settings: systematic review and meta-analysis. BMJ. 2019;366:l4185. doi: 10.1136/bmj.l4185
  • Hodkinson A, Tyler N, Ashcroft DM, et al. Preventable medication harm across health care settings: a systematic review and meta-analysis. BMC Med. 2020;18:313. doi: 10.1186/s12916-020-01774-9
  • Tariq RA, Vashisht R, Sinha A, et al. Medication dispensing errors and prevention. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023 Jan. [Updated 2023 May 2]InternetAvailable from https://www.ncbi.nlm.nih.gov/books/NBK519065/
  • Ghaleb MA, Wong ICK. Medication errors in paediatric patients. Arch Dis Child Educ Pract Ed. 2006;91(1):ep20–ep20. doi: 10.1136/adc.2005.073379
  • Ferner RE, Aronson JK. Clarification of terminology in medication errors: definitions and classification. Drug Saf. 2006;29:1011–1022. doi: 10.2165/00002018-200629110-00001
  • Errico SD, Zanon M, Radaelli D, et al. Medication errors in Pediatrics: proposals to improve the quality and safety of care through clinical risk management. 2022;8:1–7. doi: 10.3389/fmed.2021.814100
  • Benjamin L, Frush K, Shaw K, Medicine AAOFPC on PE, et al. Pediatric medication safety in the emergency department. Pediatrics. 2018;141:e20174066. doi: 10.1542/peds.2017-4066
  • Manias E, Kinney S, Cranswick N, et al. Medication errors in hospitalised children. J Paediatr Child Health. 2014;50(1):71–77. doi: 10.1111/jpc.12412
  • Shaw KN, Lillis KA, Ruddy RM, et al. Reported medication events in a paediatric emergency research network: sharing to improve patient safety. Emerg Med J. 2013;30(10):815–819. doi: 10.1136/emermed-2012-201642
  • Grissinger M. Your high-alert medication list is relatively useless without associated risk-reduction strategies. P & T. A Peer-Reviewed Journal For Formulary Management. 2016;41:598–600.
  • Alghamdi AA, Keers RN, Sutherland A, et al. Prevalence and nature of medication errors and preventable adverse drug events in paediatric and neonatal intensive care settings: a systematic review. Drug Saf. 2019;42:1423–1436. doi: 10.1007/s40264-019-00856-9
  • Prot S, Fontan JE, Alberti C, et al. Drug administration errors and their determinants in pediatric in-patients. Int J Qual Health Care. 2005;17:381–389. doi: 10.1093/intqhc/mzi066
  • Beatriz G, José OM, Inés J, et al. Medication errors in children visiting pediatric emergency departments. Farmacia Hospitalaria. 2023;47(4):141–147. doi: 10.1016/j.farma.2023.03.006
  • Al-Ramahi R, Al-Zabadi H, Al-Shareef G. Drug dosing errors in outpatient paediatric patients at primary health-care centres in Nablus: a cross-sectional study. Lancet (London, England). 2018;391(Suppl):S38. doi: 10.1016/S0140-6736(18)30404-5
  • Feleke Y, Girma B. Medication administration errors involving paediatric in-patients in a hospital in Ethiopia. Trop J Pharm Res. 2010;9(4):401–407. doi: 10.4314/tjpr.v9i4.58942
  • Taylor JA, Winter L, Geyer LJ, et al. Oral outpatient chemotherapy medication errors in children with acute lymphoblastic leukemia. Cancer. 2006;107:1400–1406. doi: 10.1002/cncr.22131
  • Weingart SN, Toro J, Spencer J, et al. Medication errors involving oral chemotherapy. Cancer. 2010;116:2455–2464. doi: 10.1002/cncr.25027
  • Otero P, Leyton A, Mariani G, et al. Medication errors in pediatric inpatients: prevalence and results of a prevention program. Pediatrics. 2008;122:e737–43. doi: 10.1542/peds.2008-0014
  • Feyissa D, Kebede B, Zewudie A, et al. Medication error and its contributing factors among pediatric patients diagnosed with infectious diseases admitted to Jimma University Medical Center, Southwest Ethiopia: prospective observational study. Integrated Pharmacy Research And Practice. 2020;9:147–153. doi: 10.2147/IPRP.S264941
  • Sutherland A, Phipps DL, Tomlin S, et al. Mapping the prevalence and nature of drug related problems among hospitalised children in the United Kingdom: a systematic review. BMC Pediatr. 2019;19:486. doi: 10.1186/s12887-019-1875-y
  • Gates PJ, Meyerson SA, Baysari MT, et al. Preventable adverse drug events among inpatients: a systematic review. Pediatrics. 2018;142:e20180805. doi: 10.1542/peds.2018-0805
  • Miller MR, Robinson KA, Lubomski LH, et al. Medication errors in paediatric care: a systematic review of epidemiology and an evaluation of evidence supporting reduction strategy recommendations. Qual Saf Health Care. 2007;16:116–126. doi: 10.1136/qshc.2006.019950
  • Ross LM, Wallace J, Paton JY. Medication errors in a paediatric teaching hospital in the UK: five years operational experience. Arch Dischildhood. 2000;83(6):492–497. doi: 10.1136/adc.83.6.492
  • Simpson JH, Lynch R, Grant J, et al. Reducing medication errors in the neonatal intensive care unit. Archives Of Disease In Childhood Fetal And Neonatal Edition. 2004;89(6):F480–2. doi: 10.1136/adc.2003.044438
  • Eslami K, Aletayeb F, Aletayeb SMH, et al. Identifying medication errors in neonatal intensive care units: a two-center study. BMC Pediatr. 2019;19:365. doi: 10.1186/s12887-019-1748-4
  • Truter A, Schellack N, Meyer JC. Identifying medication errors in the neonatal intensive care unit and paediatric wards using a medication error checklist at a tertiary academic hospital in Gauteng, South Africa. SAJCH South African Journal Of Child Health. 2017;11(1):5–10. doi: 10.7196/SAJCH.2017.v11i1.1101
  • Gates PJ, Baysari MT, Gazarian M, et al. Prevalence of medication errors among paediatric inpatients: systematic review and meta-analysis. Drug Saf. 2019;42:1329–1342. doi: 10.1007/s40264-019-00850-1
  • Bante A, Mersha A, Aschalew Z, et al. Medication errors and associated factors among pediatric inpatients in public hospitals of gamo zone, southern Ethiopia. Heliyon. 2023;9(4):e15375. doi: 10.1016/j.heliyon.2023.e15375
  • Bifftu BB, Mekonnen BY. The magnitude of medication administration errors among nurses in Ethiopia: a systematic review and meta-analysis. J Caring Sci. 2020;9(1):1–8. doi: 10.34172/jcs.2020.001
  • Ghaleb MA, Barber N, Franklin BD, et al. Systematic review of medication errors in pediatric patients. Ann Pharmacother. 2006;40:1766–1776. doi: 10.1345/aph.1G717
  • Kaushal R, Bates DW, Landrigan C, et al. Medication errors and adverse drug events in pediatric inpatients. JAMA. 2001;285(16):2114–2120. doi: 10.1001/jama.285.16.2114
  • Yin HS, Parker RM, Sanders LM, et al. Liquid medication errors and dosing tools: a randomized controlled experiment. Pediatrics. 2016;138(4):138. doi: 10.1542/peds.2016-0357
  • Joshi P, Bavdekar SB. Liquid drug dosage measurement errors with different dosing devices. Indian J Pediatr. 2019;86:382–385. doi: 10.1007/s12098-019-02894-8
  • Christopherson J, Ambrose P, Corelli RL. Accuracy of oral liquid measuring devices: comparison of dosing cup and oral dosing syringe. Ann Pharmacother. 2008;42(1):46–52. doi: 10.1345/aph.1K420
  • Hyam E, Brawer M, Herman J, et al. What’s in a teaspoon? Underdosing with acetaminophen in family practice. Fam Pract. 1989;6:221–223. doi: 10.1093/fampra/6.3.221
  • Beckett VL, Tyson LD, Carroll D, et al. Accurately administering oral medication to children isn’t child’s play. 2012;p. 838–841. doi: 10.1136/archdischild-2012-301850
  • Statement P. Metric units and the preferred dosing of orally administered liquid medications. 2015;135:3–7. doi: 10.1542/peds.2015-0072
  • Leibovitch ER, Fujiwara AS, Chun IKH, et al. Ibuprofen dosing measurement accuracy using infants’ versus children’s ibuprofen: a randomized crossover comparison. Pediat Res. 2023;94(3):1145–1150. doi: 10.1038/s41390-023-02573-7
  • Honey BL, Condren M, Phillips C, et al. Evaluation of oral medication delivery devices provided by community pharmacies 2013. Clin Pediatr (Phila). 2013;52(5):418–422. doi: 10.1177/0009922813479160
  • Zhu L, Zhou Q. Nurses should not always be blamed for medication administration errors in pediatric inpatient care. J Pediatr Nurs. 2022;64:176–177. doi: 10.1016/j.pedn.2022.02.019
  • Elder E, Johnston ANB, Wallis M, et al. The demoralisation of nurses and medical doctors working in the emergency department: a qualitative descriptive study. Int Emerg Nurs. 2020;52:100841. doi: 10.1016/j.ienj.2020.100841
  • Rasooly IR, Kern-Goldberger AS, Xiao R, et al. Physiologic monitor alarm burden and nurses’ subjective workload in a children’s hospital. Hosp Pediatr. 2021;11:703–710. doi: 10.1542/hpeds.2020-003509
  • Solano M, Jeannin M, Anxionnat R, et al. Impact of pharmacist medication review for paediatric patients: an observational study. Int J Pharm Pract. 2022;30:420–426. doi: 10.1093/ijpp/riac037
  • Rautamo M, Kvarnström K, Sivén M, et al. A focus group study about oral drug administration practices at hospital wards—aspects to consider in drug development of age-appropriate formulations for children. Pharmaceutics. 2020;12(2):109–113. doi: 10.3390/pharmaceutics12020109
  • Burlo F, Zanon D, Passone E, et al. Impact of compounded drugs on the caregivers’ burden of home therapy management in pediatric palliative care: a descriptive study. Palliat Med. 2023;37(3):384–390. doi: 10.1177/02692163231151733
  • Patidar P, Mathur A, Pathak A. Can use of pictograms reduce liquid medication administration errors by mothers? An interventional study. BMC Psychol. 2021;9:1–10. doi: 10.1186/s40359-021-00584-9
  • Williams TA, Wolf MS, Parker RM, et al. Parent dosing tool use, beliefs, and access: a Health literacy perspective. J Paediatr. 2019;215:244–251.e1. doi: 10.1016/j.jpeds.2019.08.017
  • Machongo RB, Mipando ALN. “I don’t hesitate to use the left-over antibiotics for my child” practices and experiences with antibiotic use among caregivers of paediatric patients at Zomba central hospital in Malawi. BMC Pediatr. 2022;22:1–10. doi: 10.1186/s12887-022-03528-3
  • Apaydin KÇ, Çaǧatay S, Ö Ö, et al. Competency of mothers of 0-12 year old children in preparing and scaling oral powder antibiotics. Marmara Medical Journal. 2011;24:114–118. doi: 10.5472/MMJ.2010.01670.1
  • Cullen SM, Osorio SN, Abramson EA, et al. Improving caregiver understanding of liquid acetaminophen administration at primary care visits. Pediatrics. 2022;150(2):150. doi: 10.1542/peds.2021-054807
  • Campino A, Lopez-Herrera MC, Lopez-de-Heredia I, et al. Educational strategy to reduce medication errors in a neonatal intensive care unit. Acta Paediatr. 2009;98:782–785. doi: 10.1111/j.1651-2227.2009.01234.x
  • Hu H, Wu FL, Hu F, et al. Effectiveness of education programs about oral antibiotic suspensions in pediatric outpatient services 2013 p. 34–42. doi: 10.1016/j.pedneo.2012.10.002
  • Budnitz ADS, Maribeth C, Rose KO. Adherence to label and device recommendations for over-the-counter pediatric liquid medications. Pediatrics. 2014;133(2):e283–e290. doi: 10.1542/peds.2013-2362
  • Walsh KE, Mazor KM, Roblin D, et al. Multisite parent-centered risk assessment to reduce pediatric oral chemotherapy errors. J Oncol Pract. 2013;9(1):e1–e7. doi: 10.1200/JOP.2012.000601
  • Tan L, Chen W, He B, et al. A survey of prescription errors in paediatric outpatients in multi-primary care settings: the implementation of an electronic pre-prescription system. 2022;10:1–10. doi: 10.3389/fped.2022.880928
  • Schilling S, Koeck JA, Kontny U, et al. High-alert medications for hospitalised paediatric patients - a two-step survey among paediatric clinical expert pharmacists in Germany. Pharmazie. 2022;77:207–215. doi: 10.1691/ph.2022.12025
  • Hohmann C, Eickhoff C, Klotz JM, et al. Development of a classification system for drug-related problems in the hospital setting (APS-Doc) and assessment of the inter-rater reliability. J Clin Pharm Therapeutics. 2012;37(3):276–281. doi: 10.1111/j.1365-2710.2011.01281.x
  • Walsh K, Daraiseh N, Daraiseh N. Errors and nonadherence in pediatric oral chemotherapy use. Oncology. 2016;45229(4):231–236. doi: 10.1159/000447700
  • Balit CR, Lynch A-M, Gilmore SP, et al. Lignocaine and chlorhexidine toxicity in children resulting from mouth paint ingestion: a bottling problem. J Paediatr Child Health. 2006;42(6):350–353. doi: 10.1111/j.1440-1754.2006.00871.x
  • Lajoinie A, Valla FV, Kassai B. Risk of medication error administering ciprofloxacin oral suspension in children. Eur J Clin Pharmacol. 2015;71:769–770. doi: 10.1007/s00228-015-1842-y
  • Glatstein MM, Rimon A, Koren L, et al. Unintentional oral beta agonist overdose: case report and review of the literature. Am J Ther. 2013;20:311–314. doi: 10.1097/MJT.0b013e3182002f2d
  • Henry Basil J, Premakumar CM, Mhd Ali A, et al. Prevalence, causes and severity of medication administration errors in the neonatal intensive care unit: a systematic review and meta-analysis. Drug Saf. 2022;45:1457–1476. doi: 10.1007/s40264-022-01236-6
  • Moulis F, Durrieu G, Masmoudi K, et al. Medication errors with tramadol drops in children. Eur J Clin Pharmacol. 2018;74(2):247–248. doi: 10.1007/s00228-017-2367-3
  • Grynnerup A, Fernández IS, Hernández JC, et al. A severe valproate overdose with complete recovery in a newborn. J Child Neurol. 2012;27:1072–1076. doi: 10.1177/0883073811431497
  • Haslund-Krog SS, Jørgensen IM, Dalhoff K, et al. Acceptability of prednisolone in an open-label randomised cross-over study—focus on formulation in children. Children. 2022;9(8):1236–1239. doi: 10.3390/children9081236
  • Shetty K, Thakkar H. Development of paediatric formulation of baclofen for improved safety and palatability. J Pharm Innov. 2023. doi: 10.1007/s12247-023-09715-8
  • Lam MSH. Extemporaneous compounding of oral liquid dosage formulations and alternative drug delivery methods for anticancer drugs. Pharmacotherapy. 2011;31:164–192. doi: 10.1592/phco.31.2.164
  • Nyeko R, Otim F, Obiya EM, et al. Anti-malarial drug use, appropriateness and associated factors among children under-five with febrile illnesses presenting to a tertiary health facility: a cross sectional study. Malaria j. 2023;22:1–10. doi: 10.1186/s12936-023-04534-1
  • Li S, Huang L, Zeng L, et al. Potentially inappropriate prescribing in hospitalised children: a retrospective, cross-sectional study at a tertiary children’s hospital in China. BMJ Open. 2023;13:e068680. doi: 10.1136/bmjopen-2022-068680
  • King C, Dudley J, Mee A, et al. For children admitted to hospital, what interventions improve medication safety on ward rounds? A systematic review. Arch Dischildhood. 2023;2023(7):583–588. doi: 10.1136/archdischild-2022-324772
  • Mittal R, Hamilton M. Parental calculation of pediatric paracetamol dose : a randomized trial comparing the Parental analgesia Slide with product information leaflets. 2010;p. 612–619. doi: 10.1111/j.1460-9592.2010.03332.x
  • Damiani G, Altamura G, Zedda M, et al. Potentiality of algorithms and artificial intelligence adoption to improve medication management in primary care: a systematic review. BMJ Open. 2023;13:e065301. doi: 10.1136/bmjopen-2022-065301
  • Kang NG, You MA. The effects of a smartphone-based education program designed to help mothers safely administer medication to their children. CIN - Computers Informatics Nursing. 2023;41(2):77–85. doi: 10.1097/CIN.0000000000000859
  • King WJ, Paice N, Rangrej J, et al. The effect of computerized physician order entry on medication errors and adverse drug events in pediatric inpatients. Pediatrics. 2003;112:506–509. doi: 10.1542/peds.112.3.506
  • Sutherland A, Gerrard WS, Patel A, et al. The impact of drug error reduction software on preventing harmful adverse drug events in England: a retrospective database study. BMJ Open Qual. 2022;11:1–9. doi: 10.1136/bmjoq-2021-001708
  • Bledsoe S, Van Buskirk A, RJ F, et al. Errors detected in pediatric oral liquid medication doses prepared in an automated workflow management system. Am J Health Syst Pharm. 2018;75(3):127–131. doi: 10.2146/ajhp160902
  • Satir AN, Pfiffner M, Meier CR, et al. Prescribing errors in children: what is the impact of a computerized physician order entry? Eur J Pediatr. 2023;182(6):2567–2575. doi: 10.1007/s00431-023-04894-5
  • Herziger B, Jeschke S, Melinda R, et al. Drug-handling problems and expectations of the ideal pediatric drug—reported by children and their parents. Eur J Pediatr. 2022;2022(5):2161–2171. doi: 10.1007/s00431-022-04419-6
  • Levy-Loboda T, Sheetrit E, Liberty IF, et al. Personalized insulin dose manipulation attack and its detection using interval-based temporal patterns and machine learning algorithms. J Biomed Informat. 2022;132: doi: 10.1016/j.jbi.2022.104129
  • Ameer A, Dhillon S, Peters MJ, et al. Systematic literature review of hospital medication administration errors in children. Integrated Pharmacy Research And Practice. 2015;4:153–165. doi: 10.2147/IPRP.S54998
  • Siebert JN, Ehrler F, Combescure C, et al. A mobile device application to reduce medication errors and time to drug delivery during simulated paediatric cardiopulmonary resuscitation: a multicentre, randomised, controlled, crossover trial. The Lancet Child & Adolescent Health. 2019;3(5):303–311. doi: 10.1016/S2352-4642(19)30003-3
  • Nguyen M-N, Mosel C, Grzeskowiak LE. Interventions to reduce medication errors in neonatal care: a systematic review. Ther Adv Drug Saf. 2018;9(2):123–155. doi: 10.1177/2042098617748868
  • Keers RN, Williams SD, Cooke J, et al. Impact of interventions designed to reduce medication administration errors in hospitals: a systematic review. Drug Saf. 2014;37:317–332. doi: 10.1007/s40264-014-0152-0
  • Federal U, Paulo DS, Paulo S. Medication reconciliation in pediatrics: a validation of instruments to prevent medication errors. Rev Bras Enferm. 2023;76(2):1–8. doi: 10.1590/0034-7167-2021-0755
  • Waltuch T, Munjal K, Loo GT, et al. AiRDose: developing and validating an augmented reality smartphone application for weight estimation and dosing in children. Pediatr Emerg Care. 2022;38(5):e1257–e1261. doi: 10.1097/PEC.0000000000002587
  • Engels MJ, Ciarkowski SL, Rood J, et al. Standardization of compounded oral liquids for pediatric patients in Michigan. Am J Health Syst Pharm. 2016;73:981–990. doi: 10.2146/150471
  • Chedoe I, Molendijk HA, Dittrich STAM, et al. Incidence and nature of medication errors in neonatal intensive care with strategies to improve safety. Drug Saf. 2007;30:503–513. doi: 10.2165/00002018-200730060-00004
  • Conroy S, Sweis D, Planner C, et al. Interventions to reduce dosing errors in children: a systematic review of the literature. Drug Saf. 2007;30:1111–1125. doi: 10.2165/00002018-200730120-00004
  • Sam T, Ernest TB, Walsh J, et al. A benefit/risk approach towards selecting appropriate pharmaceutical dosage forms – an application for paediatric dosage form selection. Int J Pharmaceut. 2012;435(2):115–123. doi: 10.1016/j.ijpharm.2012.05.024
  • Jm M, Vermeulen H, Apampa B, et al. Interventions to reduce medication dispensing, administration, and monitoring errors in pediatric professional healthcare settings: a systematic review. Front Pediatr. 2021;26:633064. doi: 10.3389/fped.2021.633064
  • Devarajan V, Nadeau NL, Creedon JK, et al. Reducing pediatric emergency department prescription errors. 2022p. 149. doi: 10.1542/peds.2020-014696
  • Abeln K, Cox K, Haggerty L, et al. Acceptability of multiparticulate dosing using sympfiny® delivery system with children (age 1–12). Pharmaceutics. 2022;14(11):14. doi: 10.3390/pharmaceutics14112524
  • Venables R, Batchelor H, Hodson J, et al. Determination of formulation factors that affect oral medicines acceptability in a domiciliary paediatric population. Int J Pharmaceut. 2015;480(1–2):55–62. doi: 10.1016/j.ijpharm.2015.01.023
  • Somasiri UL, Thillainathan S, Fernandopulle R, et al. Antiepileptic drugs for children: availability, suitability and acceptability. Sri Lanka Journal of Child Health. 2013;42(1):38–39. doi: 10.4038/sljch.v42i1.5293
  • Carvalho M, Almeida IF. The role of pharmaceutical compounding in promoting medication adherence. Pharmaceuticals. 2022;15(9):1091. doi: 10.3390/ph15091091
  • Heitman T, Day AJ, Bassani AS. Pediatric compounding pharmacy: taking on the responsibility of providing quality customized prescriptions. Children (Basel). 2019;6(5):66. doi: 10.3390/children6050066
  • Turner S, Longworth A, Nunn AJ, et al. Unlicensed and off label drug use in paediatric wards: prospective study. Br Med J. 1998;316:343–345. doi: 10.1136/bmj.316.7128.343
  • Giam JA, McLachlan AJ. Extemporaneous product use in paediatric patients: a systematic review. Int J Pharm Pract. 2010;16:3–10. doi: 10.1211/ijpp.16.1.0002
  • Richey RH, Shah UU, Peak M, et al. Manipulation of drugs to achieve the required dose is intrinsic to paediatric practice but is not supported by guidelines or evidence. BMC Pediatr. 2013 13;13(1). doi: 10.1186/1471-2431-13-81
  • Brion F, Nunn AJ, Rieutord A. Extemporaneous (magistral) preparation of oral medicines for children in European hospitals. Acta Paediatrica (Oslo, Norway: 1992). 2003;92(4):486–490. doi: 10.1111/j.1651-2227.2003.tb00583.x
  • Eileen Kairuz T, Gargiulo D, Bunt C, et al. Quality, safety and efficacy in the ‘off-label’ use of medicines. Curr Drug Saf. 2008;2(1):89–95. doi: 10.2174/157488607779315471
  • Vallet T, Elhamdaoui O, Berraho A, et al. Medicines acceptability in hospitalized children: an ongoing need for age-appropriate formulations. Pharmaceutics. 2020;12(8):12. doi: 10.3390/pharmaceutics12080766
  • Romano MJ, Dinh A. A 1000-fold overdose of clonidine caused by a compounding error in a 5-year-old child with attention-deficit/hyperactivity disorder. Pediatrics. 2001;108:471–472. doi: 10.1542/peds.108.2.471
  • Kato Z, Nakamura M, Yamagishi Y, et al. Pediatric thioridazine poisoning as a result of a pharmacy compounding error. Pediatr Rep. 2009;1(1):e9. doi: 10.4081/pr.2009.e9
  • Martir J, Flanagan T, Mann J, et al. Impact of food and drink administration vehicles on paediatric formulation performance: part 1-effects on solubility of poorly soluble drugs. AAPS Pharm Sci Tech. 2020;21:177. doi: 10.1208/s12249-020-01722-z
  • Held MR, Begier EM, Beardsley DS, et al. Life-threatening sepsis caused by Burkholderia cepacia from contaminated intravenous flush solutions prepared by a compounding pharmacy in another state. Pediatrics. 2006;118:e212–5. doi: 10.1542/peds.2005-2617
  • Selenic D, Dodson DR, Jensen B, et al. Enterobacter cloacae bloodstream infections in pediatric patients traced to a hospital pharmacy. Am J Health Syst Pharm. 2003;60:1440–1446. doi: 10.1093/ajhp/60.14.1440
  • Gerrard SE, Walsh J, Bowers N, et al. Innovations in pediatric drug formulations and administration technologies for low resource settings. Pharmaceutics. 2019;11(10):11. doi: 10.3390/pharmaceutics11100518
  • Sosnik A, Seremeta KP, Imperiale JC, et al. Novel formulation and drug delivery strategies for the treatment of pediatric poverty-related diseases. Expert Opin Drug Delivery. 2012;9:303–323. doi: 10.1517/17425247.2012.655268
  • Venables R, Stirling H, Batchelor H, et al. Problems with oral formulations prescribed to children: a focus group study of healthcare professionals. Int J Clin Pharm. 2015;37(6):1057–1067. doi: 10.1007/s11096-015-0152-x
  • Yuliani SH, Putri DC, Virginia DM, et al. Prevalence, risk, and challenges of extemporaneous preparation for pediatric patients in developing nations: a review. Pharmaceutics. 2023;15(3):15. doi: 10.3390/pharmaceutics15030840
  • Watson CJ, Whitledge JD, Siani AM, et al. Pharmaceutical compounding: a history, Regulatory overview, and systematic review of compounding errors. J Med Toxicol. 2021;17(2):197–217. doi: 10.1007/s13181-020-00814-3
  • Annereau M, Hinterlang M, Bienayme H, et al. Development of a hospital compounded, taste-masked, temozolomide oral suspension and 5-year real-life experience in treating paediatric patients. Pharmaceuticals. 2022;15(5):555. doi: 10.3390/ph15050555
  • Cabaleiro J. New England compounding center indictment. Int J Pharm Compd. 2015;19(2):94–102.
  • El-Rachidi S, LaRochelle JM, Morgan JA. Pharmacists and pediatric medication adherence: bridging the gap. Hosp Pharm. 2017;52(2):124–131. doi: 10.1310/hpj5202-124
  • van der Vossen AC, Al-Hassany L, Buljac S, et al. Manipulation of oral medication for children by parents and nurses occurs frequently and is often not supported by instructions. Acta Paediatr Int J Paediatr. 2019;108(8):1475–1481. doi: 10.1111/apa.14718
  • Martir J, Flanagan T, Mann J, et al. Co-administration of paediatric medicines with food and drinks in the context of their physicochemical properties—a global perspective on practices and recommendations. AAPS J. 2020;22:1–12. doi: 10.1208/s12248-020-0432-9
  • Lovell AG, Protus BM, Dickman JR, et al. Palatability of crushed over-the-counter medications. J Pain Sympt Manage. 2021;61(4):755–762. doi: 10.1016/j.jpainsymman.2020.09.020
  • Binson G, Sanchez C, Waton K, et al. Accuracy of dose administered to children using off-labelled or unlicensed oral dosage forms. Pharmaceutics. 2021;13(7):1014–1019. doi: 10.3390/pharmaceutics13071014
  • Brustugun J, Notaker N, Paetz LH, et al. Adjusting the dose in paediatric care: dispersing four different aspirin tablets and taking a proportion. Eur J Hosp Pharm. 2021;28:76–82. doi: 10.1136/ejhpharm-2019-001903
  • Watson C, Webb EA, Kerr S, et al. How close is the dose? Manipulation of 10 mg hydrocortisone tablets to provide appropriate doses to children. International Journal Of Pharmaceutics. 2018;545(1–2):57–63. doi: 10.1016/j.ijpharm.2018.04.054
  • Murshed M, Salim M, Boyd BJ. Existing and emerging mitigation strategies for the prevention of accidental overdose from oral pharmaceutical products. Eur J Pharm Biopharm. 2022;180:201–211. doi: 10.1016/j.ejpb.2022.10.002
  • Bjerknes K, Bøyum S, Kristensen S, et al. Manipulating tablets and capsules given to hospitalised children in Norway is common practice. Acta Paediatr Int J Paediatr. 2017;106(3):503–508. doi: 10.1111/apa.13700
  • Nunn A, Richey R, Shah U, et al. Estimating the requirement for manipulation of medicines to provide accurate doses for children. Eur J Hosp Pharm. 2013;20(1):3–7. doi: 10.1136/ejhpharm-2012-000133
  • Andersson ÅC, Eksborg S, Förberg U, et al. Manipulated oral and rectal drugs in a paediatric Swedish University Hospital, a registry-based study comparing two study-years, Ten years apart. Pharmaceuticals. 2023 16;16(1):8. doi: 10.3390/ph16010008
  • Zahn J, Hoerning A, Trollmann R, et al. Manipulation of medicinal products for oral administration to paediatric patients at a German university hospital: an observational study. Pharmaceutics. 2020;12(6):583. doi: 10.3390/pharmaceutics12060583
  • Johannesson J, Hansson P, Bergström CAS, et al. Manipulations and age-appropriateness of oral medications in pediatric oncology patients in Sweden: need for personalized dosage forms. Biomed Pharmacother. 2022;146:112576. doi: 10.1016/j.biopha.2021.112576
  • Okamoto GG, dos Santos KM, de Lira Nogueira L, et al. Medicine manipulation: an alternative to mitigate therapeutic gaps in the Brazilian unified Health system? PLoS One. 2022;17(11):1–18. doi: 10.1371/journal.pone.0276785
  • Saito J, Akabane M, Ishikawa Y, et al. Retrospective survey of compounded medications for children in Japan. Eur J Pharm Biopharm. 2020;155:122–127. doi: 10.1016/j.ejpb.2020.08.016
  • Nderitu, H. Prevalence of drug manipulation to obtain prescribed dose in the paediatric in-patient units in Kenyatta National hospital. Post Graduate Diploma In Biomedical Research Methodology. 2016.
  • Alessandrini E, Brako F, Scarpa M, et al. Children’s preferences for oral dosage forms and their involvement in formulation research via EPTRI (European paediatric translational research infrastructure). Pharmaceutics. 2021 13;13(5):730. doi: 10.3390/pharmaceutics13050730
  • Nadeshkumar A, Sathiadas G, Sri Ranganathan S. Rational dispensing of oral dosage forms of medicines to children at a teaching hospital in Sri Lanka. BMC Health Serv Res. 2020;20(1). doi: 10.1186/s12913-020-05246-x
  • Teigen A, Wang S, Truong BT, et al. Off-label and unlicensed medicines to hospitalised children in Norway. J Pharm Pharmacol. 2017;69:432–438. doi: 10.1111/jphp.12581
  • Richey RH, Hughes C, Craig JV, et al. A systematic review of the use of dosage form manipulation to obtain required doses to inform use of manipulation in paediatric practice. Int J Pharmaceut. 2017;518:155–166. doi: 10.1016/j.ijpharm.2016.12.032
  • Kuchenbuch M, Chemaly N, Henniene KM, et al. Off-label use and manipulations of antiepileptic drugs in children: analysis of the outpatient prescriptions in a tertiary center. Epilepsy Behav. 2018;82:133–139. doi: 10.1016/j.yebeh.2018.03.013
  • Kader R, Liminga G, Ljungman G, et al. Manipulations of oral medications in paediatric neurology and oncology care at a Swedish University Hospital: health professionals’ attitudes and sources of information. Pharmaceutics. 2021;13(10):1676. doi: 10.3390/pharmaceutics13101676
  • Walch AC, Henin E, Berthiller J, et al. Oral dosage form administration practice in children under 6 years of age: a survey study of paediatric nurses. Int J Pharmaceut. 2016;511:855–863. doi: 10.1016/j.ijpharm.2016.07.076
  • Pandolfini C, Bonati M. A literature review on off-label drug use in children. Eur J Pediatr. 2005;164(9):552–558. doi: 10.1007/s00431-005-1698-8
  • Litalien C, Autmizguine J, Carli A, et al. Providing suitable pediatric formulations for Canadian children: a call for action. Canadian Journal Of Hospital Pharmacy. 2020;73(4). doi: 10.4212/CJHP.V73I4.3023
  • Manipulation of drugs required in children (MODRIC) – a Guide for Health professionals n.d. [Accessed 30 Aug, 2023]
  • UNICEF. Paediatric antiretroviral medicines: market & supply update. Paediatric Antiretroviral Medicines : Market & Supply Update 2020:p. 0–13. [Accessed 30 Aug, 2023]
  • Münch J, Meissner T, Mayatepek E, et al. Acceptability of small-sized oblong tablets in comparison to syrup and mini-tablets in infants and toddlers: a randomized controlled trial. Eur J Pharm Biopharm. 2021;166:126–134. doi: 10.1016/j.ejpb.2021.06.007
  • Tse J, Wada K, Wang Y, et al. Impact of oscillating positive expiratory pressure device use on post-discharge hospitalizations: a retrospective cohort study comparing patients with COPD or chronic bronchitis using the Aerobika(®) and Acapella(®) devices. Int J Chron Obstruct Pulmon Dis. 2020;15:2527–2538. doi: 10.2147/COPD.S256866
  • Kaneria NS, Tuleu C, Ernest T. Opportunities for enteral drug delivery for neonates, infants, and toddlers: a critical exploration. Expert Opin Drug Delivery. 2022;19:475–519. doi: 10.1080/17425247.2022.2064449
  • Mfoafo KA, Omidian M, Bertol CD, et al. Neonatal and pediatric oral drug delivery: hopes and hurdles. Int J Pharmaceut. 2021;597:120296. doi: 10.1016/j.ijpharm.2021.120296
  • Kozakiewicz-Latała M, Nartowski KP, Dominik A, et al. Binder jetting 3D printing of challenging medicines: from low dose tablets to hydrophobic molecules. Eur J Pharm Biopharm. 2022;170:144–159. doi: 10.1016/j.ejpb.2021.11.001
  • Chatzitaki A-T, Mystiridou E, Bouropoulos N, et al. Semi-solid extrusion 3D printing of starch-based soft dosage forms for the treatment of paediatric latent tuberculosis infection. J Pharm Pharmacol. 2021;74(10):1498–1506. doi: 10.1093/jpp/rgab121
  • Chachlioutaki K, Karavasili C, Mavrokefalou E-E, et al. Quality control evaluation of paediatric chocolate-based dosage forms: 3D printing vs mold-casting method. Int J Pharmaceut. 2022;624:624. doi: 10.1016/j.ijpharm.2022.121991
  • Quodbach J, Bogdahn M, Breitkreutz J, et al. Quality of FDM 3D printed medicines for Pediatrics: considerations for formulation development, filament extrusion, printing process and printer design. Ther Innov Regul Sci. 2022;56(6):910–928. doi: 10.1007/s43441-021-00354-0
  • Xu X, Awad A, Robles-Martinez P, et al. Vat photopolymerization 3D printing for advanced drug delivery and medical device applications. JControlled Release. 2021;329:743–757. doi: 10.1016/j.jconrel.2020.10.008
  • Racaniello GF, Pistone M, Meazzini C, et al. 3D printed mucoadhesive orodispersible films manufactured by direct powder extrusion for personalized clobetasol propionate based paediatric therapies. Int J Pharmaceut. 2023;643:123214. doi: 10.1016/j.ijpharm.2023.123214
  • Pistone M, Racaniello GF, Rizzi R, et al. Direct cyclodextrin based powder extrusion 3D printing of budesonide loaded mini-tablets for the treatment of eosinophilic colitis in paediatric patients. Int J Pharmaceut. 2023;632:122592. doi: 10.1016/j.ijpharm.2023.122592
  • Lafeber I, Ruijgrok EJ, Guchelaar HJ, et al. 3D printing of pediatric medication: the end of bad tasting oral liquids?—A scoping review. Pharmaceutics. 2022;14(2):416–423. doi: 10.3390/pharmaceutics14020416
  • Scoutaris N, Ross SA, Douroumis D. 3D printed “starmix” drug loaded dosage forms for paediatric applications. Pharm Res. 2018;35(2):1–11. doi: 10.1007/s11095-017-2284-2
  • Öblom H, Sjöholm E, Rautamo M, et al. Towards printed pediatric medicines in hospital pharmacies: comparison of 2d and 3d-printed orodispersible warfarin films with conventional oral powders in unit dose sachets. Pharmaceutics. 2019;11(7):11. doi: 10.3390/pharmaceutics11070334
  • Jamróz W, Kurek M, Łyszczarz E, et al. 3D printed orodispersible films with aripiprazole. Int J Pharmaceut. 2017;533:413–420. doi: 10.1016/j.ijpharm.2017.05.052
  • Krause J, Müller L, Sarwinska D, et al. 3D printing of mini tablets for pediatric use. Pharmaceuticals. 2021;14:1–16. doi: 10.3390/ph14020143
  • Tabriz AG, Fullbrook DHG, Vilain L, et al. Personalised tasted masked chewable 3d printed fruit-chews for paediatric patients. Pharmaceutics. 2021;13(8):1301. doi: 10.3390/pharmaceutics13081301
  • Fortescue EB, Kaushal R, Landrigan CP, et al. Prioritizing strategies for preventing medication errors and adverse drug events in pediatric inpatients. Pediatrics. 2003;111:722–729. doi: 10.1542/peds.111.4.722
  • Bates DW, Boyle DL, Vander VM, et al. Relationship between medication errors and adverse drug events. J Gen Intern Med. 1995;10(4):199–205. doi: 10.1007/BF02600255
  • Watanabe JH, McInnis T, Hirsch JD. Cost of prescription drug–related morbidity and mortality. Ann Pharmacother. 2018;52:829–837. doi: 10.1177/1060028018765159
  • Alessandrini E, Walsh J, Hermans E, et al. Putting children first: understanding caregivers’ and children’s perspectives on the usability of oral and respiratory administration devices for paediatric medication. Eur J Pharm Biopharm. 2023;190:35–46. doi: 10.1016/j.ejpb.2023.07.006
  • Sajogo M, Teoh SWK, Lebedevs T. Pharmacist clinical interventions: five years’ experience of an efficient, low-cost, and future-proofed tool. Research In Social And Administrative Pharmacy. 2023;19(3):541–546. doi: 10.1016/j.sapharm.2022.12.008
  • Yin HS, Parker RM, Sanders LM, et al. Liquid medication errors and dosing tools: a randomized controlled experiment. Pediatrics. 2016;138: doi: 10.1542/peds.2016-0357
  • Belayneh A, Tessema Z. A systematic review of the stability of extemporaneous pediatric oral formulations. Sci World J. 2021;2021:8523091. doi: 10.1155/2021/8523091
  • Sosnowska K, Winnicka K, Czajkowska-Kośnik A. Stability of extemporaneous enalapril maleate suspensions for pediatric use prepared from commercially available tablets. Acta Poloniae Pharmaceutica. 2009;66:321–326.
  • Kasahun AE, Sendekie AK. Are pediatrics taking the prescribed tablet dosage form? Practices of off-label tablet modification in pediatric wards: a prospective observational study. Heliyon. 2023;9(4):e15109. doi: 10.1016/j.heliyon.2023.e15109

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.